16089 Safety of ATI-502, a novel topical JAK1/3 inhibitor, in adults with moderate to severe atopic dermatitis: Results from a phase 2a open-label trial
| Autor: | Smith, Stacy, Bhatia, Neal, Shanler, Stuart D., DeMoor, Rebecca, Schnyder, Judith |
|---|---|
| Zdroj: | In Journal of the American Academy of Dermatology December 2020 83(6) Supplement:AB170-AB170 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect